Group One Trading’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
30,749
+17,912
| +140% | +$773K | ﹤0.01% | 426 |
|
|
2025
Q1 | $444K | Sell |
12,837
-220,300
| -94% | -$7.62M | ﹤0.01% | 610 |
|
|
2024
Q4 | $6.4M | Buy |
233,137
+108,235
| +87% | +$2.97M | 0.01% | 128 |
|
|
2024
Q3 | $3.18M | Buy |
+124,902
| New | +$3.18M | 0.01% | 190 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1862 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1881 |
|
|
2023
Q4 | – | Sell |
-48,540
| Closed | -$1.28M | – | 2000 |
|
|
2023
Q3 | $1.28M | Sell |
48,540
-58,291
| -55% | -$1.54M | ﹤0.01% | 332 |
|
|
2023
Q2 | $1.84M | Sell |
106,831
-12,902
| -11% | -$222K | 0.01% | 232 |
|
|
2023
Q1 | $1.99M | Buy |
+119,733
| New | +$1.99M | 0.01% | 197 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2030 |
|
|
2022
Q3 | – | Sell |
-83,858
| Closed | -$761K | – | 2059 |
|
|
2022
Q2 | $761K | Buy |
83,858
+54,883
| +189% | +$498K | ﹤0.01% | 503 |
|
|
2022
Q1 | $294K | Sell |
28,975
-78,101
| -73% | -$792K | ﹤0.01% | 918 |
|
|
2021
Q4 | $1.79M | Buy |
+107,076
| New | +$1.79M | ﹤0.01% | 510 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2147 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2078 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1920 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1730 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1596 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1455 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1437 |
|